The Onco'Zine Brief with Peter Hofland

In this episode of The Onco’Zine Brief Peter Hofland, Ph. D., talks with Tim Blauwkamp, Ph. D., Chief Scientific Officer and co-founder of Karius. Karius, based in Redwood City, CA, has developed a non-invasive liquid biopsy, a blood test, called the Karius Test®. The test is based on next-generation sequencing of microbial cell-free DNA and can rapidly detect pathogens causing serious infections,...

In this edition of The Onco’Zine Brief, Peter Hofland, Ph. D., talks with Vince McRuiz and Margo Shoup, MD, FACS. Margo Shoup is a nationally recognized surgical oncologist who specializes in gastrointestinal cancers and sarcomas. She is also the senior vice president, and system chair of the Nuvance Health Cancer Institute, where she provides strategic and clinical leadership for all aspects of N...

In this edition of The Onco’Zine Brief Peter Hofland, Ph. D. talks with Christian Massacesi, MD, Senior Vice President, Head of Late Development Oncology R&D at AstraZeneca and with Jeffrey Skolnik, MD, Vice President, Clinical Development at Inovio Pharmaceuticals about new data and exciting developments both companies are presenting during the 2020 virtual annual meeting of the American Society...

In this edition of The Onco’Zine Brief Peter Hofland, Ph. D. talks with Armon Sharei, Ph. D. Chief Executive Officer of SQZ Biotech, about the development and manufacturing of cell therapies. Traditionally, the foundation of cancer treatment included surgery, chemotherapy, and radiation therapy. But over the last few decades, targeted therapies —drugs that specifically target molecular changes see...

In this edition of The Onco’Zine Brief, Peter Hofland talking with Helen Sabzevari, the president of Precigen. Precigen is a biopharmaceutical company dedicated to the discovery and clinical-stage development of the next generation of gene and cell therapies using precision technology. The company is developing novel therapeutic agents that are designed to target the most urgent and difficult dise...

In this episode of The Onco'Zine Brief, Peter Hofland talks with Thorsten Sperber, Global Head Medical Affairs at Immunomedics. Hofland and Sperber talk about sacituzumab govitecan, a novel antibody-drug conjugate. At the time of the interview, the drug was not yet approved, but in the weeks following the interview, the U.S. Food and Drug Administration (FDA) approved sacituzumab govitecan (Trodel...

In this episode of The Onco'Zine Brief, Peter Hofland talks with Thorsten Sperber, Global Head Medical Affairs at Immunomedics. Hofland and Sperber talk about sacituzumab govitecan, a novel antibody-drug conjugate. At the time of the interview, the drug was not yet approved, but in the weeks following the interview, the U.S. Food and Drug Administration (FDA) approved sacituzumab govitecan (Trodel...

Struggling in the heat and humidity of the summer of 2016, Terri Conneran believed that her asthma was uncontrolled. In August that year, her physician assistant prescribed her a preventive inhaler. That autumn brought the excuse of allergies, plus time for the new inhaler to take effect. By Christmas 2016, nasal congestion, and a heavy feeling chest with shortness of breath it was time to again s...

In this edition of The Onco’Zine Brief, recorded during the 42nd San Antonio Breast Cancer Symposium (SABCS), held December 10 - 14, 2019 in San Antonio, Texas, Peter Hofland talks with leading breast cancer experts, and patients about metastatic breast cancer and health related quality of life hrQoL issues including sexual intimacy, bone health and joint pain. In this roundtable, panelists will a...

In this episode The Onco’Zine Brief, recorded during the 42nd San Antonio Breast Cancer Symposium (SABCS) held December 10 – 14, 2019 in San Antonio, Texas, Peter Hofland talks with Susan Rafte, a 25+ year survivor of metastatic breast cancer and patient advocate. In 1994, eight and a half months after birth to her daughter Marika, Susan Rafte, only 30 years old, was diagnosed with stage III ducta...

In this edition of The Onco’Zine Brief Peter Hofland talks with Dr. Muhammed Murtaza and Dr. Thomas Slavin about liquid biopsies Murtaza is Assistant Professor and co-Director of the Center for Noninvasive Diagnostics at TGen in Phoenix, AZ, and Dr. Slavin is Assistant Clinical Professor, Departments of Medical Oncology & Therapeutics Research and Population Sciences, Division of Clinical Cancer G...

In this edition of The Onco’Zine Brief Peter Hofland talks with Catherine Ivy, the Founder and President of the Ben & Catherine Ivy Foundation. The Ben & Catherine Ivy Foundation, established in 2005, is the largest non-government organization supporter of brain tumor - including glioblastoma (GBM) - research in the world. To date, the Ivy Foundation has funded clinical trials and basic science in...

Today in The Onco’Zine Brief Peter Hofland talks with Dr. Michael Caligiuri and Deana and Steve Campbell Physician-in-Chief Distinguished Chair, President of City of Hope National Medical Center in Los Angeles, California, and Dr. Jianhua Yu, professor in the Department of Hematology & Hematopoietic Cell Transplantation at City of Hope, and a Scholar of The Leukemia & Lymphoma Society. By combinin...

In this edition of The Onco’Zine Brief Peter Hofland talks with Holly LaDuca, a certified genetic counselor and manager of clinical Research oncology at Ambry Genetics. Identifying an individual’s genetic information is nothing new. And while, over the last decades, most people have become familiar with genetic ancestry testing, or genetic genealogy, as a way for people interested in their family...

In this edition of The Onco’Zine Brief Peter Hofland talks with Laura Panos Smith, a certified genetic counselor and vice president of commercial operations at Ambry Genetics. Ms. Smith leads a large team responsible for the implementation of key strategic initiatives for Ambry Genetics. This includes the daily support and education for patients and healthcare providers, as well as marketing and s...

Today in The Onco’Zine Brief Peter Hofland talks with Diane Zipursky Quale. Together with her late husband John Quale, Diane, who holds a BA from Stanford University and a JD from the National Law Center, George Washington University, is Co-Founder and Director of the Bladder Cancer Advocacy Network (BCAN), the only national advocacy organization devoted to advancing bladder cancer research and su...

In this episode of the Onco’Zine Brief Peter Hofland reports from the 2019 annual meeting of the American Society of Clinical Oncology – ASCO – which was held May 31st – June 4th, 2019. Hofland talks with: - Dr. Hartmut Juhl, the Chief Executive Officer of Indivumed, a physician-led, integrated global oncology company. The company offers specialized products and services designed to support the di...

In this episode of The Onco’Zine Brief Peter Hofland report from the annual meeting of the American Society of Clinical Oncology – ASCO – which was held May 31st – June 4th, 2019. The American Society of Clinical Oncology is the world's leading professional organization for physicians and oncology professionals caring for people with cancer. During the annual meeting Peter Hofland spoke with: •Ann...

In this episode of The Onco’Zine Brief, recorded during the annual meeting of the American Society of Clinical Oncology, ASCO, being held May 31 – June 4, 2019, Peter Hofland talks with Lee Schwartzberg MD, FACP, is a Medical Oncologist and Hematologist at West Cancer Center, Germantown, TN, and Dr. Shannon Westin, MD, MPH., FACOG, Associate Professor, Department of Gynecologic Oncology and Reprod...

This week The Onco’Zine Brief comes from Chicago, Illinois and the annual meeting of the American Society of Clinical Oncology (ASCO) being held May 31 – June 4, 2019. In this episode Peter Hofland talks with a Eugene Luskin, Chief Executive Officer of Redmond, Washington-based Vyrty. As part of a growing push to let patients control and manage their own medical history, Luskin’s Vyrty has launche...

This week The Onco’Zine Brief comes from Chicago, Illinois and the annual meeting of the American Society of Clinical Oncology (ASCO) being held May 31 – June 4, 2019. In this episode Peter Hofland talks with a Adil Akhtar, MD, an Oncologist and Palliative Care Expert, Associate Professor, Department of Medical Oncology & Hematology at the Oakland University-William Beaumont School of Medicine. He...

In this edition of The Onco’Zine Brief Peter Hofland talks with Greg Van Wyk, Chief Executive Officer and Chief Medical Officer of Noxopharm, a clinical-stage Australian drug development company with offices in Sydney, New York and Hong Kong. The company is developing a number of drug candidates including an advanced dosage formulation of the generic anti-cancer agent called idronoxil, which is de...

In this edition of The Onco’Zine Brief Peter Hofland talks with Dr. Salman Hyder, Professor in Tumor Angiogenesis and professor of biomedical sciences in the College of Veterinary Medicine and the Dalton Cardiovascular Research Center at the University of Missouri, in Columbia, Missouri. Together with a team of researchers Dr. Hyder found that a combination drug therapy, reduces the spread of trip...

In this edition of The Onco’Zine Brief Peter Hofland talk with Dr. Lisa Stearns, the founder and medical director of Center for Pain and Supportive Care, in Phoenix, Arizona. An internationally recognized Interventional Pain Specialist, board certified in hospice and palliative medicine and pain management, Dr. Stearns’ passion for changing the face of acute and chronic pain-treatment is evidenced...

In this edition of The Onco’Zine Brief Peter Hofland talks with Mr. Isaac Israel, the CEO of Kitov Pharma, a pharmaceutical drug development company developing new options to treat osteoarthritis pain and hypertension simultaneously, as well as novel anticancer drugs. The company is developing an investigational drug called NT-219, a novel small molecule drug designed to targets two signal protein...